Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jul 01, 2005 (Vol. 25, No. 13)

Southwestern Program in Genomics Applications

  • Some data, educational material
  • Schizophrenic, disorganized
The genomics and proteomics of the cellular response to injury is the focus of this rather boringly titled site from the U.T. Southwestern Medical center in Dallas, TX. Organization of the site is not inspired, and a good reason appears to be that the site's design is schizophrenic-split between providing general, PR-type information about the center and relevant genomic information on the subject. This latter info is tucked into four disparate sections: Protocols/Reagents, Antibody Production, Polymorphism Production, and Software Production. It's dissapointing with all of that "production" that there is so little "product" to be had at the site. A minor surprise is a set of deucational Power Points on Bioinformatics, Genetic Immunization, Antibody Production, and Genetic Synthesis, but even that is compromised by a rather lame organization of the material. A site crying out for direction.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »